NCT02142946

Brief Summary

The primary objective of this project is to track changes over time in balance control parameters measured during stance and gait for different groups of multiple sclerosis (MS) patients. Our primary goal is to determine whether these changes in balance control over time predict transitions in MS progression to a more disease affected state, and are different from changes over time for patients with balance deficits due to vestibular sensory disorders. A part of this goal is also to determine whether these changes in balance control are correlated with changes in patients' self-reported deficits and are similar to those changes in balance control of patients with peripheral vestibular loss. The secondary objective is to determine for multiple sclerosis (MS) patients the relationship of their balance parameters to different gait speeds, in order to advise them on, and promote via feedback, safe walking speeds. Fulfilling the first of our objectives would lead to better tracking of MS disease changes over time, earlier quantification of onset of symptoms suggesting a worsening of disease status, and, we assume, greater patient satisfaction knowing that quantification of symptoms fits subjective feelings of balance deficits during stance and gait. Achieving the second objective would lead to improved balance during gait. We aim to carry out these objectives using equipment (SwayStar) which we have proven is sensitive to MS induced balance deficits {2}, but costs far less to operate and maintain than previously used quantification tools. We aim to investigate the balance deficits during gait in different MS patient groups using a multimodal approach with a SwayStar system (analysis of balance during stance and gait in terms of trunk-pelvis movements near the centre of mass) and patient questionnaires.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 20, 2014

Completed
3.9 years until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 6, 2025

Status Verified

April 1, 2025

Enrollment Period

7.7 years

First QC Date

May 16, 2014

Last Update Submit

April 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in balance during stance and gait

    Measurement of trunk sway as balance measure during stance and gait trials

    1 year

Study Arms (10)

RIS MS patients

Radiologically Isolated Syndrome (RIS) MS patients

CIS MS patients

Clinically Isolated Syndrome (CIS) patients during a stable phase

RRMS patients

Relapsing-remitting (RR) MS patients during a stable phase

SPMS Patients

Secondary progressive MS patients (SPMS)

PPMS Patients

Primary progressive MS patients (PPMS)

Controls

Age and gender matched controls

CI Patients

Cochlear Implant patients pre- and post-operatively

UVL Patients

Unilateral vestibular loss patients in acute and compensated state

Chronic UVL

Chronic unilateral vestibular loss patients

Phobic

Phobic vertigo patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with MS or UVL

You may qualify if:

  • Balance deficits due to inner ear disease or MS

You may not qualify if:

  • Inability to walk without a walking aid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lab for Exp Otoneurology, University Hospital Basel

Basel, CH-4031, Switzerland

RECRUITING

Study Officials

  • John HJ Allum, DSc

    University Hospital, Basel, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John Allum, DSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2014

First Posted

May 20, 2014

Study Start

April 1, 2018

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

April 6, 2025

Record last verified: 2025-04

Locations